- Home
- Companies
- us virgin islands
- therapeutic development
Refine by
Therapeutic Development Suppliers Serving Us Virgin Islands
172 companies found
based inVancouver, BRITISH COLUMBIA (CANADA)
At AbCellera, team is everything. When great people share a vision and work together, they can truly have a positive impact on the world. That™s why we hire for character and intelligence, not for CVs or experience. We look for people with drive and ...
We search, decode, and analyze natural immune systems to find antibodies that our partners can develop into drugs that improve ...
based inFrederick, MARYLAND (USA)
In 2019, ProMedDx and GLAS Bio were acquired by Precision for Medicine, part of Precision Medicine Group. This new combination significantly bolstered the selection, scientific prowess and solutions available to customers from a single partner. With ...
Advancing your research into hematological malignancies, immunology, and other related areas requires access to high quality human bone marrow mononuclear cells. Precision for Medicine has an extensive inventory of normal, healthy donors with ...
based inSouth San Francisco, CALIFORNIA (USA)
Sutro Biopharma is a clinical stage company pioneering a compelling and unique way of discovering, developing and manufacturing therapeutics. Our focus is aimed primarily on next-generation cancer therapeutics – antibody drug conjugates, bispecific ...
Conventional methods for expressing proteins utilize cell lines originating from bacteria, yeast, insects, plants, or mammals. Because these methods require intact, functioning cells, the biochemical and biophysical parameters under which proteins ...
based inMontclair, NEW JERSEY (USA)
Theranica develops advanced, clinically proven, safe and affordable digital therapeutics, addressing some of the world’s most prevalent neurological pain diseases. We harness a pain inhibition mechanism known as Conditioned Pain Modulation (CPM). ...
based inMilpitas, CALIFORNIA (USA)
ASC Therapeutics is a fully incorporated biopharmaceutical company focusing on the development of curative therapeutic products that are enabled by our proprietary gene editing platform, TARGATT and other gene editing technologies developed after 12 ...
Genome editing technologies enables permanent modifications to the genome by harnessing the activities of certain enzymes (e.g. nucleases and integrase) and invoking DNA repair mechanisms at specific locations in the genome. As a ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
based inPlanegg, GERMANY
We are a biotech company that independently develops innovative drugs and diagnostics for personalised treatment of cardiovascular diseases. We have a unique product pipeline that we are consistently moving into clinical trials. Our lead compound ...
based inDurham, NORTH CAROLINA (USA)
Xenobiotic Detection Systems International, Inc (XDSI) is one of the world’s leading laboratories offering dioxin screening by cell-based bioassay and we have more than 20 years of experience in using this methodology. We deliver affordable ...
The AhR also has been shown to play a key regulatory role in endogenous physiological responses as well as human disease and it has become an important new target for the development of therapeutic chemicals. Since ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
An i-body is a human protein that belongs to the class of next generation antibodies. The i-body is built on the scaffold of a human protein and engineered with two loops that mimic the shape of shark antibodies. These loops are responsible for ...
based inDijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
based inDublin, IRELAND
Our mission is to help clients accelerate the development of drugs and devices that save lives and improve quality of life. We offer a full range of consulting, clinical development and commercialisation services from a global network of offices in ...
based inLexington, MASSACHUSETTS (USA)
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of Type 2 Diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying ...
based inBoston, MASSACHUSETTS (USA)
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro ...
based inWendelsheim, GERMANY
MODAG aims to provide a novel approach for treating neurodegenerative diseases by combining targeted small molecule therapeutics with the right diagnostic tools. Our first objective is to demonstrate clinical proof-of-concept with our lead compound ...
based inLausanne, SWITZERLAND
ReproNovo, established in 2021, is a company with a focus on reproductive medicine and women's health. The team, composed of experts with years of experience, is dedicated to developing innovative therapeutic solutions targeting male and female ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
SB-743921 hydrochloride is a potent inhibitor of the mitotic kinesin KSP (Eg5), with a Ki of 0.1 ...
based inVictoria, BRITISH COLUMBIA (CANADA)
IPA (ImmunoPrecise Antibodies NASDAQ: IPA ) is a biotherapeutic research company that brings industry leading antibody discovery services and complex artificial intelligence technologies together - to lead its pharmaceutical partners into the era of ...
based inArcugnano (VI), ITALY
Since 1983 we have been working to become the international landmark in lasertherapy and magnetotherapy for multidisciplinary use: from physiotherapy to rehabilitation, from pain management – both muscular and articular - to sports medicine and ...
based inCarmel, INDIANA (USA)
Sword Diagnostics is a cutting-edge life sciences company created in response to the rapidly evolving needs of the research and pharmaceutical communities. Although researchers are discovering thousands of biomarkers associated with both healthy and ...
Sword scientists specialize in the development of qualitative or quantitative bioanalytical methods that measure cellular biomolecules active in a specific disease state. Cell-based assays are bioanalytical methods that measure the ...
based inBreitenfurt, AUSTRIA
Privately held OncoQR ML, based in Vienna/Austria, is a pre-clinical biotech company that offers novel therapeutic cancer vaccines based on its unique, proprietary and broadly applicable S-TIR™ (Specific Total Immune Remodulation) technology ...
Lead candidate TYG100 (formerly OQR100, out-licensed to TYG oncology Ltd.) is an “Active Checkpoint Control Immunotherapy (ACCI)” for the treatment of gastroenterological cancers such as pancreatic, stomach, colon, and gastro-esophageal ...
